Introduction
Methods
Treatment
Endpoints
Statistical analysis
Results
Mortality and baseline characteristics
Atrial fibrillation on day of admission
Mortality | |||
---|---|---|---|
AF free | AF |
p-value | |
AF on the day of admission | 17/789 (2.2 %) | 3/41 (7.3 %) | 0.036 |
AF 24–72 h after admission | 11/771 (1.4 %) | 2/14 (14.3 %) | < 0.001 |
AF > 72 after admission | 8/750 (1.1 %) | 0/18 (0 %) | > 0.999 |
Univariate | OR | 95 % CI |
p-value |
---|---|---|---|
Age (per year) | 1.123 | 1.065–1.184 | < 0.001 |
Gender male | 1.733 | 0.682–4.406 | 0.248 |
BMI | 1.035 | 0.901–1.188 | 0.628 |
Current smoker | 0.275 | 0.090–0.835 | 0.023 |
Diabetes | 4.774 | 1.852–12.304 | 0.001 |
Hypertension | 2.514 | 1.029–6.140 | 0.043 |
Hypercholesterolaemia | 0.957 | 0.344–2.665 | 0.933 |
Killip class > 1 | 8.314 | 3.365–20.544 | < 0.001 |
Previous MI | 3.942 | 1.387–11.200 | 0.010 |
Previous PCI | 0.584 | 0.077–4.428 | 0.603 |
Systolic BP (per 10 mmHg) | 0.641 | 0.516–0.796 | < 0.001 |
Diastolic BP (per 10 mmHg) | 0.530 | 0.383–0.732 | < 0.001 |
Tirofiban study medication | 0.254 | 0.084–0.766 | 0.015 |
Culprit vessel LADa
| 3.061 | 1.080–8.677 | 0.035 |
Culprit vessel LCxa
| 0.856 | 0.099–7.413 | 0.887 |
TIMI grade flow post PCI < 3 | 7.444 | 2.939–18.856 | < 0.001 |
AF on the day of admission | 3.585 | 1.007–12.764 | 0.049 |
Zwolle risk score | 1.638 | 1.416–1.894 | < 0.001 |
Multivariate analysis
| |||
AF on the day of admission | 3.537 | 0.739–16.927 | 0.114 |
Zwolle risk score | 1.625 | 1.404–1.880 | < 0.001 |
Atrial fibrillation 24–72 h after admission
Univariate | OR | 95 % CI |
p-value |
---|---|---|---|
Age (per year) | 1.111 | 1.048–1.177 | < 0.001 |
Gender male | 2.146 | 0.754–6.105 | 0.152 |
BMI | 1.055 | 0.913–1.219 | 0.468 |
Current smoker | 0.375 | 0.118–1.186 | 0.095 |
Diabetes | 5.911 | 2.052–17.025 | 0.001 |
Hypertension | 1.800 | 0.646–5.015 | 0.261 |
Hypercholesterolaemia | 1.044 | 0.329–3.314 | 0.942 |
Killip class > 1 | 7.275 | 2.574–20.556 | < 0.001 |
Previous MI | 4.300 | 1.331–13.895 | 0.015 |
Previous PCI | 0.792 | 0.103–6.117 | 0.823 |
Systolic BP (per 10 mmHg) | 0.708 | 0.555–0.902 | 0.005 |
Diastolic BP (per 10 mmHg) | 0.611 | 0.423–0.883 | 0.009 |
Tirofiban study medication | 0.254 | 0.071–0.906 | 0.035 |
Culprit vessel LADa
| 4.317 | 1.194–15.606 | 0.026 |
Culprit vessel LCXa
| N/A | ||
TIMI grade flow post PCI < 3 | 4.061 | 1.258–13.106 | 0.019 |
AF 24–72 h after admission | 11.515 | 2.300–57.662 | 0.003 |
Zwolle risk score | 1.564 | 1.345–1.818 | < 0.001 |
Multivariate analysis | |||
AF 24–72 h after admission | 13.476 | 2.138–84.954 | 0.006 |
Zwolle risk score | 1.548 | 1.311–1.828 | < 0.001 |